Details for New Drug Application (NDA): 214442
✉ Email this page to a colleague
NDA 214442 describes CAPTOPRIL, which is a drug marketed by Aiping Pharm Inc, Ajanta Pharma Ltd, Andas 5 Holding, Apothecon, Aurobindo Pharma Usa, Chartwell Rx, Corepharma, Cosette, Dava Pharms Inc, Egis Pharms, G And W Labs Inc, Hikma Intl Pharms, Oxford Pharms, Prinston Inc, Purepac Pharm, Sandoz, Seton Pharms, Strides Pharma Intl, Teva, Watson Labs, Wockhardt Bio Ag, Ivax Sub Teva Pharms, and Rising, and is included in thirty-one NDAs. It is available from thirteen suppliers. Additional details are available on the CAPTOPRIL profile page.
The generic ingredient in CAPTOPRIL is captopril; hydrochlorothiazide. There are fifteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the captopril; hydrochlorothiazide profile page.
The generic ingredient in CAPTOPRIL is captopril; hydrochlorothiazide. There are fifteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the captopril; hydrochlorothiazide profile page.
Summary for 214442
| Tradename: | CAPTOPRIL |
| Applicant: | Aiping Pharm Inc |
| Ingredient: | captopril |
| Patents: | 0 |
Pharmacology for NDA: 214442
| Mechanism of Action | Angiotensin-converting Enzyme Inhibitors |
Medical Subject Heading (MeSH) Categories for 214442
Suppliers and Packaging for NDA: 214442
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| CAPTOPRIL | captopril | TABLET;ORAL | 214442 | ANDA | AiPing Pharmaceutical, Inc. | 11788-135 | 11788-135-01 | 100 TABLET in 1 BOTTLE (11788-135-01) |
| CAPTOPRIL | captopril | TABLET;ORAL | 214442 | ANDA | AiPing Pharmaceutical, Inc. | 11788-136 | 11788-136-01 | 100 TABLET in 1 BOTTLE (11788-136-01) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 12.5MG | ||||
| Approval Date: | Jan 27, 2023 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 25MG | ||||
| Approval Date: | Jan 27, 2023 | TE: | AB | RLD: | No | ||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 50MG | ||||
| Approval Date: | Jan 27, 2023 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
